메뉴 건너뛰기




Volumn 20, Issue 6, 2014, Pages 747-750

The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age

Author keywords

case control study; Epstein Barr virus; interaction; Multiple sclerosis; risk factors in epidemiology; smoking

Indexed keywords

COTININE; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN G ANTIBODY; TOBACCO SMOKE; BIOLOGICAL MARKER;

EID: 84899108969     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513507820     Document Type: Article
Times cited : (19)

References (10)
  • 1
    • 84878556201 scopus 로고    scopus 로고
    • Smoking as a risk factor for multiple sclerosis
    • Salzer J, Hallmans G, Nyström M, et al. Smoking as a risk factor for multiple sclerosis. Mult Scler. 2013 ; 8: 1022-1027
    • (2013) Mult Scler , vol.8 , pp. 1022-1027
    • Salzer, J.1    Hallmans, G.2    Nyström, M.3
  • 2
    • 84858216423 scopus 로고    scopus 로고
    • Smoking: Effects on multiple sclerosis susceptibility and disease progression
    • Wingerchuk DM. Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord. 2012 ; 5: 13-22
    • (2012) Ther Adv Neurol Disord , vol.5 , pp. 13-22
    • Wingerchuk, D.M.1
  • 3
    • 84895733434 scopus 로고    scopus 로고
    • Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples
    • Salzer J, Nyström M, Hallmans G, et al. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. :
    • Mult Scler
    • Salzer, J.1    Nyström, M.2    Hallmans, G.3
  • 4
    • 77951728213 scopus 로고    scopus 로고
    • Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk
    • Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology. 2010 ; 74: 1365-1371
    • (2010) Neurology , vol.74 , pp. 1365-1371
    • Simon, K.C.1    Van Der Mei, I.A.2    Munger, K.L.3
  • 5
    • 84866887824 scopus 로고    scopus 로고
    • Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis
    • Sundqvist E, Sundström P, Linden M, et al. Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology. 2012 ; 79: 1363-1368
    • (2012) Neurology , vol.79 , pp. 1363-1368
    • Sundqvist, E.1    Sundström, P.2    Linden, M.3
  • 6
    • 84872427093 scopus 로고    scopus 로고
    • Negative interaction between smoking and infectious mononucleosis in the risk of MS
    • Riise T, Pugliatti M, Casetta I, et al. Negative interaction between smoking and infectious mononucleosis in the risk of MS. ECTRIMS 5th Joint Triennial Congress ; Amsterdam, The Netherlands ;..
    • ECTRIMS 5th Joint Triennial Congress
    • Riise, T.1    Pugliatti, M.2    Casetta, I.3
  • 7
    • 84871267380 scopus 로고    scopus 로고
    • Vitamin D as a protective factor in multiple sclerosis
    • Salzer J, Hallmans G, Nyström M, et al. Vitamin D as a protective factor in multiple sclerosis. Neurology. 2012 ; 79: 2140-2145
    • (2012) Neurology , vol.79 , pp. 2140-2145
    • Salzer, J.1    Hallmans, G.2    Nyström, M.3
  • 8
    • 13444300937 scopus 로고    scopus 로고
    • Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
    • Vineis P, Airoldi L, Veglia F, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ. 2005 ; 330: 277-281
    • (2005) BMJ , vol.330 , pp. 277-281
    • Vineis, P.1    Airoldi, L.2    Veglia, F.3
  • 9
  • 10
    • 84859652622 scopus 로고    scopus 로고
    • Recommendations for presenting analyses of effect modification and interaction
    • Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012 ; 41: 514-520
    • (2012) Int J Epidemiol , vol.41 , pp. 514-520
    • Knol, M.J.1    Vanderweele, T.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.